Obstetrics and gynecology
-
Obstetrics and gynecology · Nov 2006
Randomized Controlled Trial Multicenter StudyControlled-release misoprostol vaginal insert in parous women for labor induction: a randomized controlled trial.
To assess the ability of a controlled-release misoprostol vaginal insert to induce labor using dose reservoirs of 25, 50, 100, and 200 microg. ⋯ I.
-
Obstetrics and gynecology · Nov 2006
Adverse events detected by clinical surveillance on an obstetric service.
Adverse events are adverse patient outcomes resulting from medical care. We performed this study to estimate the rate of adverse events and potential adverse events-errors that have a high likelihood of causing patient harm-occurring during obstetric care. ⋯ II-2.
-
Obstetrics and gynecology · Nov 2006
Tenure of academic chairs in obstetrics and gynecology: a 25-year perspective.
To assist in predicting future leadership needs, this longitudinal study examines turnover and net retention rates among chairs at university obstetrics and gynecology departments between 1981 and 2005. ⋯ II-2.
-
Obstetrics and gynecology · Nov 2006
Patient safety in obstetrics and gynecology: an agenda for the future.
The effect of medical errors and unsafe systems of care has had a profound effect on the practice of obstetrics and gynecology. From 1975 to 2000, medical malpractice costs for obstetrician-gynecologists have risen nearly four-fold higher than that of other medical costs. In addition, it has been estimated that defensive medicine may cost society $80 billion per year. ⋯ This article discusses other medical specialty society efforts that have been successful in addressing the area of patient safety. Efforts to better track quality outcomes has been initiated by the American College of Surgeons through the National Surgical Quality Improvement Project, and the American Society of Anesthesiologists has demonstrated both dramatically improved outcomes and reduced liability costs through a concerted patient safety effort. The author proposes changes in four areas to specifically address patient safety in obstetrics and gynecology, including: the development of reliable and reproducible quality control measures (and a system to track them); national closed claim reviews to better understand and address the most important safety and liability areas for obstetrician-gynecologists; work prospectively with pharmaceutical and surgical device manufacturers to develop innovative new products that would increase the likelihood of safe outcomes; and create a culture of safety in obstetrics and gynecology by incorporating safety education into all levels of training.